Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136383 · ClinicalTrials.gov registry record · Phase 2
Comparing Paroxetine and Duloxetine on Cardiovascular Measures
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00136383 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 40 participants.
The verdict
NCT00136383, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
Interventions
- DRUG paroxetine versus duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136383
The ClinicalTrials.gov registry entry for NCT00136383 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which paroxetine versus duloxetine is the first listed.
NCT00136383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00136383 about?
NCT00136383 is a clinical study titled "Comparing Paroxetine and Duloxetine on Cardiovascular Measures". This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
What is the current status of trial NCT00136383?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2005-03. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00136383?
The interventions under investigation include: paroxetine versus duloxetine (DRUG).
Who is sponsoring clinical trial NCT00136383?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.